These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28437278)

  • 21. Beneficial effect of early infusion of landiolol, a very short-acting beta-1 adrenergic receptor blocker, on reperfusion status in acute myocardial infarction.
    Kiyokuni M; Konishi M; Sakamaki K; Kawashima C; Narikawa M; Doi H; Iwata K; Tomari S; Nakayama N; Komura N; Mitsuhashi T; Yano H; Sugano T; Ishigami T; Endo T; Ishikawa T; Yamanaka T; Kimura K
    Int J Cardiol; 2016 Oct; 221():321-6. PubMed ID: 27404699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-dependent effect of landiolol, a new ultra-short-acting β(1)-blocker, on supraventricular tachyarrhythmias in postoperative patients.
    Taenaka N; Kikawa S
    Clin Drug Investig; 2013 Jul; 33(7):505-14. PubMed ID: 23728899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Landiolol infusion during general anesthesia does not prevent postoperative atrial fibrillation in patients undergoing lung resection.
    Aoyama H; Otsuka Y; Aoyama Y
    Gen Thorac Cardiovasc Surg; 2016 Dec; 64(12):735-741. PubMed ID: 27553581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose.
    Wariishi S; Yamashita K; Nishimori H; Fukutomi T; Yamamoto M; Radhakrishnan G; Sasaguri S
    Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):811-3. PubMed ID: 19666952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias.
    Atarashi H; Kuruma A; Yashima M; Saitoh H; Ino T; Endoh Y; Hayakawa H
    Clin Pharmacol Ther; 2000 Aug; 68(2):143-50. PubMed ID: 10976545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A low-dose β1-blocker effectively and safely slows the heart rate in patients with acute decompensated heart failure and rapid atrial fibrillation.
    Kobayashi S; Murakami W; Myoren T; Tateishi H; Okuda S; Doi M; Nao T; Wada Y; Matsuzaki M; Yano M
    Cardiology; 2014; 127(2):105-13. PubMed ID: 24296610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood Pressure Recovery After Dobutamine Antagonism: Partial With Landiolol, None With Esmolol.
    Krumpl G; Ulč I; Trebs M; Kadlecová P; Hodisch J; Husch B
    Clin Pharmacol Drug Dev; 2022 Mar; 11(3):309-317. PubMed ID: 34655181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection.
    Nakano T; Shimizu K; Kawashima O; Kamiyoshihara M; Nagashima T; Ibe T; Takeyoshi I
    J Clin Pharm Ther; 2012 Aug; 37(4):431-5. PubMed ID: 22059486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventive effect of low-dose landiolol on postoperative atrial fibrillation study (PELTA study).
    Sasaki K; Kumagai K; Maeda K; Akiyama M; Ito K; Matsuo S; Katahira S; Suzuki T; Suzuki Y; Kaiho Y; Sugawara Y; Tsuji I; Saiki Y
    Gen Thorac Cardiovasc Surg; 2020 Nov; 68(11):1240-1251. PubMed ID: 32372277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Landiolol attenuates the cardiovascular response to tracheal intubation.
    Goyagi T; Tanaka M; Nishikawa T
    J Anesth; 2005; 19(4):282-6. PubMed ID: 16261464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized controlled trial of landiolol, a short-acting beta-1 adrenergic receptor blocker, illustrating changes in high-molecular weight adiponectin levels after elective percutaneous coronary intervention.
    Kiyokuni M; Konishi M; Saigusa Y; Iwata K; Nakayama N; Komura N; Sugano T; Ishigami T; Ishikawa T; Yamanaka T; Tamura K; Kimura K
    Heart Vessels; 2020 Nov; 35(11):1510-1517. PubMed ID: 32533314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-finding study of landiolol hydrochloride: a short-acting β1-blocker for controlling heart rate during coronary computed-tomography angiography in Japan.
    Hirano M; Hara K; Ikari Y; Jinzaki M; Iino M; Hamada C; Kuribayashi S
    Adv Ther; 2013 Sep; 30(9):803-18. PubMed ID: 24062147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Landiolol infusion attenuates increase in heart rate, but does not prevent increase in blood pressure in response to emergence from anesthesia and tracheal extubation].
    Horiuchi T; Uchida S; Kadoi Y; Saito S; Sasaki M; Yoshikawa D; Sugaya T; Shimada H; Maruyama N; Satoh J; Nara T; Takahashi K
    Masui; 2010 Sep; 59(9):1178-84. PubMed ID: 20857678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Experience of Landiolol Use for an Advanced Heart Failure Patient With Severe Hypotension.
    Nitta D; Kinugawa K; Imamura T; Endo M; Amiya E; Inaba T; Maki H; Hatano M; Komuro I
    Int Heart J; 2015; 56(5):564-7. PubMed ID: 26370372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose continuous infusion of landiolol can reduce adrenergic response during tracheal intubation in elderly patients with cardiovascular disease.
    Hirata N; Miyashita R; Watanabe A; Yamakage M
    J Anesth; 2010 Oct; 24(5):786-8. PubMed ID: 20652333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of postoperative landiolol administration for atrial fibrillation after off pump coronary artery bypass surgery.
    Fujii M; Bessho R; Ochi M; Shimizu K; Terajima K; Takeda S
    J Cardiovasc Surg (Torino); 2012 Jun; 53(3):369-74. PubMed ID: 22249647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-blind, placebo-controlled, phase III study of the short-acting β1-adrenergic receptor blocker landiolol hydrochloride for coronary computed tomography angiography in Japanese patients with suspected ischemic cardiac disease.
    Hirano M; Yamashina A; Hara K; Ikari Y; Jinzaki M; Iino M; Yamaguchi T; Tanimoto M; Kuribayashi S;
    Clin Drug Investig; 2014 Jan; 34(1):53-62. PubMed ID: 24174275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of low-dose landiolol, an ultrashort-acting β-blocker, on postoperative atrial fibrillation in patients undergoing pulmonary resection for lung cancer.
    Nojiri T; Yamamoto K; Maeda H; Takeuchi Y; Funakoshi Y; Maekura R; Okumura M
    Gen Thorac Cardiovasc Surg; 2011 Dec; 59(12):799-805. PubMed ID: 22173677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does intravenous landiolol, a β1-adrenergic blocker, affect stroke volume variation?
    Wajima Z; Shiga T; Imanaga K; Inoue T
    J Anesth; 2013 Dec; 27(6):890-4. PubMed ID: 23653103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature.
    Matsuishi Y; Mathis BJ; Shimojo N; Kawano S; Inoue Y
    Vasc Health Risk Manag; 2020; 16():111-123. PubMed ID: 32308404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.